5 Best Pharmaceutical Stocks to Buy According to Cathie Wood

Page 5 of 5

1. AbbVie Inc. (NYSE: ABBV)

Wood’s Stake Value: $59,858,000
Percentage of Cathie Wood’s 13F Portfolio: 0.11%
Number of Hedge Fund Holders: 72

AbbVie Inc. (NYSE: ABBV) develops, manufactures, discovers, and sells pharmaceuticals across the globe and was founded in 2012. It is placed first on our list of 10 best pharmaceutical stocks to buy, according to Cathie Wood. AbbVie stock has returned more than 24% to investors over the course of the past twelve months.

AbbVie’s Venclyxto has been by approved European Commission to treat acute myeloid leukemia, found in adult patients. For Q1 2021, the company reported net revenue of $13.01 billion, up 51% YoY. EPS during the quarter was $2.95. The company has raised its FY 2022 EPS guidance to $7.27-$7.47 from earlier set guidance of $6.69 and $6.89.

ARK Investment holds more than 553,117 shares in the company worth over $59 million, representing 0.11% of their portfolio. ARK Investment added AbbVie to its portfolio in the last quarter. Out of the hedge funds being tracked by Insider Monkey, Berkshire Hathaway is a leading shareholder in AbbVie Inc. (NYSE: ABBV), with 22.87 million shares worth more than $2.47 billion.

You can also take a peek at Top Pharmaceutical Companies in India and Top 10 Health Insurance Stocks to Buy.

Page 5 of 5